HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PROPHYLACTIC USE OF 15(S)15 METHYL PGF2α BY INTRAMUSCULAR ROUTE FOR CONTROL OF POSTPARTUM BLEEDING - A COMPARATIVE TRIAL WITH METHYLERGOMETRINE.

Abstract
In a multicentre trial (3 centres) the safety and efficacy of an intramuscular injection of 125 µg of 15(S)15 methyl PGF2α (Prostin 15M, Upjohn) was compared with methylergometrine for prophylactic control of bleeding during the third stage of labour. Three hundred patients were recruited for the study - 150 to each treatment group. The duration of the third stage was shorter in the patients (4.4 minutes) treated with Prostin 15M compared to the methylergometrine group (8.6 minutes). Similarly the blood loss during the third stage was reduced by 50% of that observed in the methylergometrine group (72 ml vs 145 ml). Prostin 15M, when used prophylactically was better than methylergometrine in controlling the blood loss during the third stage of labour.
AuthorsP Bhattacharya, Devi Pk, S Jain, Kanthamani Cr, Raghavan Ks
JournalActa obstetricia et gynecologica Scandinavica (Acta Obstet Gynecol Scand) Vol. 67 Issue S145 Pg. 13-15 (Jan 1988) ISSN: 1600-0412 [Electronic] United States
PMID29120046 (Publication Type: Journal Article)
Copyright1988 Acta Obstet Gynecol Scand.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: